<PAGE>

                                UNITED STATES
                     SECURITIES AND EXCHANGE COMMISSION
                           Washington, D.C. 20549

                                 FORM 10-Q/A
                               AMENDMENT NO. 1
                                      TO

(Mark One)

         /X/    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
                      THE SECURITIES EXCHANGE ACT OF 1934
                  FOR THE QUARTERLY PERIOD ENDED JUNE 30, 1998

                                       OR

         / /    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
                      THE SECURITIES EXCHANGE ACT OF 1934

     FOR THE TRANSITION PERIOD FROM ________________ TO ________________.

                         COMMISSION FILE NUMBER 0-22743


                        VISTA MEDICAL TECHNOLOGIES, INC.
             (Exact name of registrant as specified in its charter)


                  DELAWARE                                    94-3184035
      (State or other jurisdiction of                     (I.R.S. Employer
       incorporation or organization)                      Identification No.)

                         5451 AVENIDA ENCINAS, SUITE A
                               CARLSBAD, CA 92008
                    (Address of principal executive offices)
                                 (760) 603-9120
                (Registrant's phone number, including area code)

                            -------------------------


INDICATE BY CHECK MARK WHETHER THE REGISTRANT (1) HAS FILED ALL REPORTS 
REQUIRED TO BE FILED BY SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 
1934 DURING THE PRECEDING 12 MONTHS (OR FOR SUCH SHORTER PERIOD THAT THE 
REGISTRANT WAS REQUIRED TO FILE SUCH REPORTS) AND (2) HAS BEEN SUBJECT TO 
SUCH FILING REQUIREMENTS FOR THE PAST 90 DAYS:

                         (1)   YES /x/    NO / /
                         (2)   YES /x/    NO / /

As of August 3, 1998 there were 13,486,944 shares of $.01 par value common 
stock outstanding.


                                       1

<PAGE>

Item 6.  Exhibits and Reports on Form 8-K

A)       Exhibits

    (1)  10.1 Amendment Number One to Sales Agreement between the Company and 
              Medtronic, Inc., dated June 9, 1998

    (1)  10.2 Amended and Restated Sales Agreement between the Company and 
              Medtronic, Inc., dated June 26, 1998

         10.3 Manufacturing Supply Agreement between the Company and Kaiser 
              Electro-Optics, Inc., dated July 19, 1995

    (1)  11.1 Statement Regarding Computation of Per Share Earnings

    (1)  27.1 Financial Data Schedule

------------------------
(1)  Incorporated by reference to the same-numbered exhibit to the Company's 
     Form 10-Q filed June 30, 1998.  

B)       Reports on Form 8-K

         No reports on Form 8-K were filed by the Company during the three 
         months ended June 30, 1998.

                                       2

<PAGE>

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the 
registrant has duly caused this report to be signed on its behalf by the 
undersigned thereunto duly authorized.


                                   VISTA MEDICAL TECHNOLOGIES, INC.

Date: September 18, 1998           /s/ John R. Lyon
      -----------------------      --------------------------------------
                                   John R. Lyon
                                   President, Chief Executive Officer and
                                   Director


Date: September 18, 1998           /s/ Robert J. De Vaere
      -----------------------      ------------------------------------------
                                   Robert J. De Vaere
                                   Vice President of Finance & Administration
                                   & Chief Financial Officer
                                   (Principal financial and accounting officer)


                                       3